Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company save search
Lilly to Participate in Guggenheim Oncology Conference
Published: 2023-02-03 (Crawled : 15:20) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
conference
AC Immune to Present at the SVB Securities Global Biopharma Conference
Published: 2023-02-02 (Crawled : 13:20) - globenewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -2.31%
H: 0.39%
C: -0.99%
ACIU | $2.42 -2.42% -2.48% 86K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
biopharma global conference
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook
Published: 2023-02-02 (Crawled : 12:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -2.31%
H: 0.39%
C: -0.99%
FHTX A | $8.515 -0.41% -0.41% 20K
|
Health Technology
|
| O: 4.18%
H: 4.12%
C: -4.79%
financial growth pipeline
Global Report on Seborrheic Dermatitis Market Size & Share Worth USD 5 billion, to Record a 11.1% CAGR by 2030 | Seborrheic Dermatitis Industry Trends, Segmentation, Analysis & Forecast by FnF
Published: 2023-02-01 (Crawled : 17:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
global report dermatitis market
U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
fda for
Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity
Published: 2023-01-26 (Crawled : 17:00) - biospace.com/
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
capacity direct
UPSHER-SMITH EXPANDS FLUOXETINE PRODUCT LINE TO INCLUDE AN ORAL SOLUTION
Published: 2023-01-26 (Crawled : 17:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
solution
Myocardial Infarction (MI) Market is Projected to Grow at a Minimal CAGR of 1.61% During the Study Period (2019-2032) | Assesses DelveInsight
Published: 2023-01-26 (Crawled : 16:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
study market
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
Published: 2023-01-26 (Crawled : 14:00) - globenewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
VERU | $5.75 -2.71% -2.78% 1.2M
|
Health Technology
|
| O: 1.31%
H: 0.81%
C: -4.52%
report financial results
AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial
Published: 2023-01-26 (Crawled : 12:20) - globenewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
ACIU | $2.42 -2.42% -2.48% 86K
|
Health Technology
|
| O: 14.1%
H: 0.0%
C: -7.34%
aci-24 for vaccine trial alzheimer’s positive aci-24.060 anti-amyloid beta
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | $86.075 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
VTRS | $12.17 -0.16% -0.16% 7.1M
|
Health Technology
|
| O: 0.0%
H: 0.87%
C: 0.69%
NVS | $85.85 -0.29% -0.29% 3.9M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
BHC | $7.86 -0.51% 0.0% 1.8M
|
Health Technology
|
| O: 2.77%
H: 3.28%
C: -0.23%
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: 0.0%
leo pharma global report therapeutics psoriasis market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $98.55 0
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVSEF | $86.075 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
PFE 2 d | $44.06 -0.63% -0.02% 24M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
NVS | $85.85 -0.29% -0.29% 3.9M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
GSK | $34.83 -0.85% 0.03% 3.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
ABT | News | $111.79 -0.41% 0.0% 3.8M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
global alzheimer's market
Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle Park
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
research
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
drug abbvie report china
Global Cybersecurity Market Analysis Report 2022-2027 - Increasing Focus on Solution-centric Security Capabilities and Rising Vulnerabilities on Endpoint Devices
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
SPLK | $104.57 -2.26% -2.31% 2.7M
|
Technology Services
|
| O: 2.6%
H: 1.85%
C: -0.59%
MSFT A | $258.35 -2.36% -2.42% 29M
|
Technology Services
|
| O: 0.64%
H: 0.6%
C: -0.19%
CYBR | $145.9 -1.93% 0.1% 490K
|
Technology Services
|
| O: 3.52%
H: 1.37%
C: 0.01%
CHKP | $128.48 -0.36% -0.37% 570K
|
Technology Services
|
| O: -2.03%
H: 1.12%
C: -0.55%
global report cybersecurity security market
World Connected Logistics Markets Report 2022-2029: Rising Need for Efficient Warehouse Management Driving Growth with Increasing Adoption of IoT and Cloud Technologies
Published: 2023-01-24 (Crawled : 12:00) - prnewswire.com
IBM | $136.94 0.4% -0.1% 3.8M
|
Technology Services
|
| O: -0.1%
H: 0.0%
C: 0.0%
INFY | $19.28 -1.18% 0.1% 5.5M
|
Technology Services
|
| O: 0.5%
H: 0.0%
C: 0.0%
HON | $202.66 -2.28% -2.33% 4.5M
|
Producer Manufacturing
|
| O: 0.77%
H: 1.82%
C: 1.46%
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 11.05%
H: 0.0%
C: -9.9%
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: -0.97%
H: 0.53%
C: -0.26%
INTC M | $30.315 0.41% 0.41% 58M
|
Electronic Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
management report for growth iot cloud
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published: 2023-01-23 (Crawled : 10:00) - biospace.com/
TAK | $15.97 1.46% 0.0% 3.5M
|
Health Technology
|
| O: 0.25%
H: 0.4%
C: -0.25%
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
license china
U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab
Published: 2023-01-19 (Crawled : 00:00) - prnewswire.com
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
drug for approval response food
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results Announcement
Published: 2023-01-19 (Crawled : 17:00) - biospace.com/
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
announcement conference for financial results
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | $15.97 1.46% 0.0% 3.5M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
NVO | $136.79 3.36% 1.17% 1.8M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NVS | $85.85 -0.29% -0.29% 3.9M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News | $164.61 -0.56% -0.01% 6.8M
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: 0.0%
GSK | $34.83 -0.85% 0.03% 3.6M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LLY M | $339.08 2.53% 0.83% 5.7M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BMY A | $74.45 2.31% -0.54% 10M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | News | $46.02 -2.58% -2.65% 3.5M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD | $84.51 3.83% 3.69% 13M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
AMGN | $245.12 -0.57% -0.58% 3.1M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
global report growth market
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.